T13	Artificial_process 66 75	Treatment
T18	Subject 109 117	patients
T19	Pharmacological_substance 223 247	immunosuppressive agents
T23	Disorder 18 47	idiopathic pulmonary fibrosis
T24	Disorder 79 108	idiopathic pulmonary fibrosis
T27	GGPs 694 708	growth factors
T33	Disorder 451 480	idiopathic pulmonary fibrosis
T34	GGPs 0 14	Growth factors
T36	Anatomical_entity 537 541	lung
T38	Pharmacological_substance 172 187	corticosteroids
T44	Subject 833 841	patients
T46	GGPs 638 652	growth factors
E3	Artificial_process:T13 Theme:T18 disorder:T24
N65	Reference E3 UMLS:C0087111	Therapeutic procedure
N81	Reference T18 UMLS:C0030705	Patients
N84	Reference T19 UMLS:C0021081	Immunosuppressive Agents
N95	Reference T23 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N98	Reference T24 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N107	Reference T27 UMLS:C0018284	Growth Factor
N127	Reference T33 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N132	Reference T34 UMLS:C0018284	Growth Factor
N138	Reference T36 UMLS:C0024109	Lung
N148	Reference T38 UMLS:C0001617	Adrenal Cortex Hormones
N165	Reference T44 UMLS:C0030705	Patients
N173	Reference T46 UMLS:C0018284	Growth Factor
T50	Pharmacological_substance 314 329	corticosteroids
N1	Reference T50 UMLS:C0001617	Adrenal Cortex Hormones
R1	Subject_Disorder Arg1:T18 Arg2:T24	
T51	Positive_regulation 553 562	increased
E5	Positive_regulation:T51 Theme:E8
N5	Reference E5 UMLS:C1879547	Activation action
T53	Positive_regulation 443 450	driving
E7	Positive_regulation:T53 Theme:T33
N6	Reference E7 UMLS:C1879547	Activation action
T15	Molecular_function 563 571	activity
E8	Molecular_function:T15 Theme:T46
N9	Reference E8 UMLS:C1149472	growth factor activity
T5	Correlation 543 552	involving
E9	Correlation:T5 Theme:E11 Theme2:E5
N10	Reference E9 UMLS:C0332281	Associated with
T29	Biological_process 489 525	abnormal, dysregulated wound healing
E11	Biological_process:T29 atLoc:T36
N15	Reference E11 UMLS:C0151692	Impaired wound healing
